Exscientia (EXAI) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Exscientia Revenue Highlights


Latest Revenue (Y)

$24.96M

Latest Revenue (Q)

$5.29M

Main Segment (Y)

Licensing Fees - Upfront Payments and Research Funding

Main Geography (Y)

UNITED STATES

Exscientia Revenue by Period


Exscientia Revenue by Year

DateRevenueChange
2023-12-31$24.96M-24.14%
2022-12-31$32.90M20.01%
2021-12-31$27.41M107.98%
2020-12-31$13.18M10.39%
2019-12-31$11.94M-

Exscientia generated $24.96M in revenue during NA 2023, up -24.14% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Exscientia Revenue by Quarter

DateRevenueChange
2024-03-31$5.29M117.70%
2023-12-31$2.43M-72.64%
2023-09-30$8.88M195.48%
2023-06-30$3.01M-47.82%
2023-03-31$5.76M-29.74%
2022-12-31$8.20M16.59%
2022-09-30$7.03M-18.75%
2022-06-30$8.66M-5.52%
2022-03-31$9.16M120.82%
2021-12-31$4.15M-82.49%
2021-09-30$23.69M5762.11%
2021-06-30$404.13K-94.43%
2021-03-31$7.26M24.73%
2020-12-31$5.82M367.54%
2020-09-30$1.25M-48.50%
2020-06-30$2.42M-
2020-03-31$2.42M6.20%
2019-12-31$2.28M-
2019-09-30$2.28M-
2019-06-30$2.28M-
2019-03-31$2.28M-

Exscientia generated $5.29M in revenue during Q1 2024, up 117.70% compared to the previous quarter, and up 64.51% compared to the same period a year ago.

Exscientia Revenue Breakdown


Exscientia Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Licensing Fees - Opt-in Payments and Milestones Achieved--$18.58M
Service Fees$104.00K--
Licensing Fees - Upfront Payments and Research Funding$19.98M$26.55M$8.32M
Service fees-$670.00K$452.00K

Exscientia's latest annual revenue breakdown by segment (product or service), as of Dec 23: Licensing Fees - Upfront Payments and Research Funding (99.48%), and Service Fees (0.52%).

Quarterly Revenue by Product

Product/ServiceDec 23Jun 23Dec 22Sep 22Jun 22
Licensing Fees - Upfront Payments and Research Funding$16.97M$3.01M$6.81M$5.96M$6.80M
Service Fees-----
Service fees---$334.00K$336.00K
Licensing Fees - Opt-in Payments and Milestones Achieved-----

Exscientia's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Licensing Fees - Upfront Payments and Research Funding (100.00%).

Exscientia Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
UNITED STATES$14.38M$21.00M$22.20M
FRANCE$5.08M--
Other Countries Not Individually Disclosed--$3.56M
Rest of Europe$619.00K$6.22M-

Exscientia's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (71.64%), FRANCE (25.28%), and Rest of Europe (3.08%).

Exscientia Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$249.38M$128.18M
KYMRKymera Therapeutics$78.59M$3.74M
ADAPAdaptimmune Therapeutics$60.28M$128.37M
RXRXRecursion Pharmaceuticals$44.58M$13.79M
PIRSPieris Pharmaceuticals$42.81M-
VECTVectivBio$27.34M$676.00K
RLAYRelay Therapeutics$25.55M-
EXAIExscientia$24.96M$5.29M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
MREOMereo BioPharma Group$10.00M-
IPSCCentury Therapeutics$2.23M$771.00K
LIFEaTyr Pharma$353.00K$235.00K
PDSBPDS Bio--
ZURAZura Bio--
LPTXLeap Therapeutics--
ELEVElevation Oncology--
UBXUnity Bio--
SANASana Bio--
GLUEMonte Rosa Therapeutics-$4.70M
AVIRAtea Pharmaceuticals--

EXAI Revenue FAQ


Exscientia's yearly revenue for 2023 was $24.96M, representing a decrease of -24.14% compared to 2022. The company's yearly revenue for 2022 was $32.9M, representing an increase of 20.01% compared to 2021. EXAI's yearly revenue for 2021 was $27.41M, representing an increase of 107.98% compared to 2020.

Exscientia's quarterly revenue for Q1 2024 was $5.29M, a 117.70% increase from the previous quarter (Q4 2023), and a -8.18% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.43M, a -72.64% decrease from the previous quarter (Q3 2023), and a -70.37% decrease year-over-year (Q4 2022). EXAI's quarterly revenue for Q3 2023 was $8.88M, a 195.48% increase from the previous quarter (Q2 2023), and a 26.29% increase year-over-year (Q3 2022).

Exscientia's revenue growth rate for the last 3 years (2021-2023) was -8.96%, and for the last 5 years (2019-2023) was 109.03%.

Exscientia's revenue streams in c 23 are Service Fees, and Licensing Fees - Upfront Payments and Research Funding. Service Fees generated $104K in revenue, accounting 0.52% of the company's total revenue Licensing Fees - Upfront Payments and Research Funding generated $19.98M in revenue, accounting 99.48% of the company's total revenue, down -24.77% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Exscientia was Licensing Fees - Upfront Payments and Research Funding. This segment made a revenue of $19.98M, representing 99.48% of the company's total revenue.